Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
Feasibility and Preliminary Efficacy of a Digital Story Intervention to Facilitate Decision-Making in Patients With Myeloid Cancers Considering Allogeneic Hematopoietic Cell Transplantation
University of Rochester
120 participants
Jan 15, 2026
INTERVENTIONAL
Conditions
Summary
This is a two-arm pilot randomized trial that assesses the feasibility and preliminary efficacy of a digital story and values clarification intervention (Considering alloHCT: Opportunities for Patient Reflection During Decision-Making via Digital Stories \[CHORDS\]) compared to usual care among patients with myeloid cancers considering allogeneic hematopoietic cell transplantation (alloHCT).
Eligibility
Inclusion Criteria12
- Patients
- Age \>21 years old
- Diagnosis of myeloid cancer (AML, MDS, myelofibrosis, CML, or MDS/MPN)
- Being considered for alloHCT
- Able to provide informed consent
- Able to speak English. The reason for this is because the digital stories have been created in the English language and their multimedia form cannot easily be translated.
- Age \>18 years old
- Selected by the patient when asked if there is a "family member, partner, friend or caregiver with whom you discuss or who can be helpful in health-related matters."
- Caregiver may be paid/professional or informal caregiver
- Able to provide informed consent
- Able to speak English
- \) Hematologists of the patients who agree to enroll on the study who are part of Wilmot Cancer Institute.
Exclusion Criteria4
- Caregivers
- \) None
- Hematologists
- \) None
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The CHORDS intervention consists of 1) digital stories created by individuals who previously underwent consultation for alloHCT and 2) explicit values clarification exercises designed to help patients reflect on their emotions and clarify what matters to them, including a) an interactive workbook, and b) best-worst scaling (BWS).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07263074